Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Yinmei, Zhou"'
Autor:
Tim Flerlage, MD, Kimberly Fan, MD, Yidi Qin, MSc, Asya Agulnik, MD, MPH, Anita V. Arias, MD, Cheng Cheng, PhD, Lama Elbahlawan, MD, Saad Ghafoor, MD, Caitlin Hurley, MD, Jennifer McArthur, MD, R. Ray Morrison, MD, Yinmei Zhou, MSc, H.J. Park, PhD, Joseph A. Carcillo, MD, Melissa R. Hines, MD
Publikováno v:
Critical Care Explorations, Vol 5, Iss 10, p e0976 (2023)
OBJECTIVES:. To use supervised and unsupervised statistical methodology to determine risk factors associated with mortality in critically ill pediatric oncology patients to identify patient phenotypes of interest for future prospective study. DESIGN:
Externí odkaz:
https://doaj.org/article/921e455b4a7545fcb62978ba852f2f1d
Autor:
David Spencer Mangum, Johnathon D. Bishop, Yinmei Zhou, Cheng Cheng, Seth E. Karol, Jeffrey E. Rubnitz, Raul C. Ribeiro, Jun J. Yang, Charles G. Mullighan, Sima Jeha, Ching‐Hon Pui, Hiroto Inaba
Publikováno v:
British Journal of Haematology. 200:338-343
Of 1003 children with acute lymphoblastic leukaemia (ALL), 147 (14.7%) presented without peripheral blood blasts (PBB). While absence of PBB was not independently associated with survival outcomes when compared to those with PBB, patients without PBB
Autor:
Cheng Cheng, Yinmei Zhou, Ching-Hon Pui, Matthew M. Klairmont, Tanja A. Gruber, Sima Jeha, John K. Choi, Hiroto Inaba, Yiwei Liu
Publikováno v:
Mod Pathol
Little is known about B-lymphoblastic leukemia (B-ALL) that lacks expression of terminal deoxynucleotidyl transferase (TdT). To address this, we performed the largest study to date of TdT-negative B-ALL using data from St. Jude Total XV and XVI clini
Autor:
Yinmei Zhou, Ching-Hon Pui, Hiroto Inaba, Sima Jeha, Yiwei Liu, Cheng Cheng, Mary V. Relling, John C. Panetta, Teodoro Bottiglieri, Jun J. Yang, Erland Arning, Seth E. Karol
Publikováno v:
Cancer Chemother Pharmacol
PURPOSE: We evaluated effects of asparaginase dosage, schedule, and formulation on CSF asparagine in children with acute lymphoblastic leukemia (ALL). METHODS: We evaluated CSF asparagine (2114 samples) and serum asparaginase (5007 samples) in 482 ch
Autor:
Cheng Cheng, Raul C. Ribeiro, Francisco Pedrosa, Marcia Pedrosa, Ester Vinhas, Elaine Coustan-Smith, Alessandra Maria de Luna Ramos, Arli Pedrosa, Norma Lucena-Silva, Gaston K. Rivera, Yinmei Zhou, Dario Campana, Mecneide Mendes Lins
Publikováno v:
Blood. 135:1458-1466
Treatment-related mortality is common among children with acute lymphoblastic leukemia (ALL) treated in poor-resource settings. We applied a simplified flow cytometric assay to identify patients with precursor B-cell ALL (B-ALL) at very low risk (VLR
Autor:
Rebecca Epperly, Emilia M. Pinto, Teresa Santiago, Heather Sheppard, Michael R. Clay, Christopher Morton, Phuong Nguyen, Yinmei Zhou, Mary Woolard, Carla O'Reilly, Julie Justice, Walter Akers, Melissa Johnson, Asa Karlstrom, Cheng Cheng, Gerard Zambetti, Andrew Davidoff, Raul Ribeiro, Christopher DeRenzo
Publikováno v:
Cancer Research. 83:1197-1197
Outcomes for pediatric patients with unresectable, metastatic, or relapsed adrenocortical carcinoma (ACC) are dismal despite aggressive management with multimodality therapies. CAR T cell therapy (CAR T) is a promising approach to improve outcomes fo
Autor:
Jonas W. Ravich, Sujuan Huang, Yinmei Zhou, Patrick Brown, Ching-Hon Pui, Hiroto Inaba, Cheng Cheng, Stephen Gottschalk, Brandon M. Triplett, Challice L. Bonifant, Aimee C. Talleur
Publikováno v:
Transplant Cell Ther
BACKGROUND: CD19-specific chimeric antigen receptor (CAR) T-cell therapies, including the FDA-approved tisagenlecleucel, induce high rates of remission in pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL). Howeve
Autor:
Aimee C Talleur, Camille Keenan, Stephen Gottschalk, Gabriela Maria Marón Alfaro, Melissa Hines, Brandon M. Triplett, Cheng Cheng, Akshay Sharma, Kim E. Nichols, Caitlin Hurley, Yinmei Zhou
Publikováno v:
Br J Haematol
Chimeric antigen receptor T-cell (CAR T-cell) therapy is associated with significant toxicities secondary to immune activation, including a rare but increasingly recognised severe toxicity resembling haemophagocytic lymphohistiocytosis (carHLH). We r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c2441d781c86025702417c8443f9ae8
https://europepmc.org/articles/PMC8756350/
https://europepmc.org/articles/PMC8756350/
Autor:
Karol, Seth E., Pan, Haitao, Yinmei, Zhou, Rubnitz, Jeffrey E., Bhakta, Nickhill, Jeha, Sima, Relling, Mary V., Crews, Kristine R, Panetta, John C, Morin, Cara, Cheng, Cheng, Pui, Ching-Hon, Inaba, Hiroto, McCarville, M Beth
Publikováno v:
In Blood 2 November 2023 142 Supplement 1:2837-2837
Autor:
Kimura, Shunsuke, Pölönen, Petri, Montefiori, Lindsey, Caldwell, Kenneth, Iacobucci, Ilaria, Chen, Chelsey, Brown, Anthony, Han, Katie, Liu, Yen-Chun, Chang, Yunchao, Cheng, Zhongshan, Yinmei, Zhou, Park, Chun Shik, Mitchell, Sharnise, Reyes, Noemi, Yeoh, Allen, Attarbaschi, Andishe, Moore, Andrew, Manabe, Atsushi, Buldini, Barbara, Chiew, Kean Hui, Li, Chi Kong, Pui, Ching-Hon, Qu, Chunxu, Tomizawa, Daisuke, Paietta, Elisabeth, Locatelli, Franco, Escherich, Gabriele, Qingsong, Gao, Muhle, Hannah Elisa, Marquart, Hanne Vibeke, de Groot-Kruseman, Hester A., Rowe, Jacob M., Stary, Jan, Trka, Jan, Choi, John Kim, Meijerink, Jules P.P., Takita, Junko, Pawinska-Wasikowska, Katarzyna, Schmiegelow, Kjeld, Eguchi, Mariko, Schrappe, Martin, Zimmermann, Martin, Takagi, Masatoshi, Maybury, Melissa, Svaton, Michael, Reiterova, Michaela, Kicinski, Michal, Kato, Motohiro, Spinelli, Orietta, Mazilier, Pauline, Thomas, Paul G., Masetti, Riccardo, Kotecha, Rishi Sury, Pieters, Rob, Elitzur, Sarah, Luger, Selina M, Shen, Shuhong, Jeha, Sima, Kornblau, Steven M., Skoczen, Szymon, Miyamura, Takako, Vincent, Tiffaney, Imamura, Toshihiko, Conter, Valentino, Tang, Yanjing, Gu, Zhaohui, Roberts, Kathryn G., Teachey, David T., Crews, Kristine R, Cheng, Cheng, Yang, Jun J., Inaba, Hiroto, Mullighan, Charles G.
Publikováno v:
In Blood 2 November 2023 142 Supplement 1:845-845